Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma
ACS Applied Materials & Interfaces · 21.05.2025 · 17 (20) · 29318-29340
DOI: 10.1021/acsami.5c03616 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 09.05.2025. Verfasst von Sonika Chibh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali, Punjab 140306, India. Hauptthemen laut MEDLINE: Glioma, RNA, Small Interfering, Disulfides, Molybdenum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Science and Engineering Research Board.
Abstract (Originalsprache)
Exfoliated 2D transition-metal dichalcogenide (TMDCs)-based nanomaterials have captured a huge biomedical territory owing to their supreme physicochemical properties. However, the tedious and harsh chemical exfoliation of bulk MoS2 impacts its utility in the biological domain. The study introduces a facile and environmentally benign way of shape-tunable exfoliation of bulk MoS2 materials in an aqueous dispersion using designed self-assembled, tetrapeptide (Fmoc-HCKF-OH)-based nanostructures, generating hybrid MoS2-peptide nanosystems for both tumor-targeted [employing folic acid (FA) functionalization] and NIR-responsive delivery of anticancer siRNA/drug in glioma. Exfoliated MoS2-peptide NSs here prove to be an excellent photothermal agent by inducing a temperature elevation upto ∼51 °C upon 808 nm NIR absorption. Enhanced siRNA/Dox loading onto the 2D flat morphology of MoS2-peptide NSs resulted in ∼90% cancer cell death in C6 glioma cells under NIR exposure. The expression of the Galectin-1 oncogene was suppressed following the treatment. Thereafter, analysis in the C6 glioma syngeneic rat model demonstrated a significant reduction (>10 fold) in tumor volume with siRNA/Dox-loaded FA-MoS2-peptide NSs + NIR as compared to the phosphate buffer saline-treated control group. Further, in vivo biodistribution studies confirmed the higher targetability of FA-conjugated hybrid NSs. Taken together, our findings promote the utility of TMDC-based nanomaterials in conjecture with a biocompatible peptide scaffold as a trimodal chemo, gene, and phototherapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali, Punjab 140306, India.
- Division of Endocrinology, CSIR-Central Drug Research Institute, Sector-10, Jankipuram extension, Lucknow 226031, India.
- Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.
- Quantum Materials and Devices Unit, Institute of Nano Science and Technology, Sector-81, Mohali, Punjab 140306, India.
- School of Basic, Applied and Biosciences, RIMT University, Mandi-Gobindgarh, Punjab 147301, India.
- BRIC-National Agri-Food and Biomanufacturing Institute (BRIC-NABI) (Formerly National Agri-Food Biotechnology Institute), Department of Biotechnology, Ministry of Science and Technology (Government of India), Sector-81,…
ORCID-Profile: Shahjad Ali, Jibanananda Mishra, Md Ehesan Ali, Jiban Jyoti Panda
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Chibh, S., Aggarwal, N., Gupta, N., Ali, S., Mishra, J., Tiwari, S., Ali, M. E., Mishra, D. P., & Panda, J. J. (2025). Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma. ACS Applied Materials & Interfaces, 17(20), 29318-29340. https://doi.org/10.1021/acsami.5c03616
Vancouver
Chibh S, Aggarwal N, Gupta N, Ali S, Mishra J, Tiwari S, et al. Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma. ACS Applied Materials & Interfaces. 2025;17(20):29318-29340. doi:10.1021/acsami.5c03616
BibTeX
@article{Chibh2025,
author = {Chibh, Sonika and Aggarwal, Nidhi and Gupta, Neelam and Ali, Shahjad and Mishra, Jibanananda and Tiwari, Siddharth and Ali, Md Ehesan and Mishra, Durga Prasad and Panda, Jiban Jyoti},
title = {Photoresponsive and Shape-Switchable MoS 2 –Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {20},
pages = {29318--29340},
doi = {10.1021/acsami.5c03616}
}
EUVIMED